CVIR Endovascular最新文献

{"title":"Is uterine artery embolisation a safe and effective modality to treat submucosal fibroids?","authors":"Rayhab Mashal, Neeral Patel, Bhavna Pitrola, Thomas Sewell, Asmaa Al-Kufaishi, Shabnam Taheri, Mohamad Hamady","doi":"10.1186/s42155-025-00546-x","DOIUrl":"https://doi.org/10.1186/s42155-025-00546-x","url":null,"abstract":"<p><strong>Highlights: </strong>• Uterine fibroid embolization (UFE) reduced the median volume of dominant submucosal leiomyomas by 64% and achieved over 90% devascularization in 94.8% of cases.• High patient satisfaction was observed, with 84.5% of patients successfully discharged without needing further intervention.• Severe adverse events were rare, affecting only 3.2% of patients, with pelvic infections being the most significant.• Mild adverse events occurred in 16.8% of patients, including infections requiring antibiotics and persistent vaginal discharge.• A multidisciplinary approach is essential for managing patients with submucosal leiomyomas undergoing UFE to ensure optimal treatment outcomes.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"49"},"PeriodicalIF":1.2,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144163481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Controlled expansion stent grafts versus legacy stent grafts for transjugular intrahepatic portosystemic shunt: a single-centre retrospective study on the incidence of hepatic encephalopathy.","authors":"Afonso Fonseca, Rui Ramos, Élia Coimbra, António Caetano, Teresa Neves, Rafaela Pereira, Inês Conde Vasco, Marta Alves, Tiago Bilhim","doi":"10.1186/s42155-025-00557-8","DOIUrl":"10.1186/s42155-025-00557-8","url":null,"abstract":"<p><strong>Purpose: </strong>Assess incidence of hepatic encephalopathy (HE) after transjugular intrahepatic portosystemic shunt (TIPS) in patients treated with 8-10 mm Controlled Expansion diameter VIATORR® (VCX) versus 10 mm diameter first-generation VIATORR® (Legacy) stent-grafts.</p><p><strong>Materials and methods: </strong>Single-centre retrospective study (January 2015 to March 2024), including 132 adult patients with cirrhosis treated with TIPS due to complications of portal hypertension. Outcomes included post-TIPS new onset overt HE, ascites response, re-bleeding, mortality and portal pressure gradient (PPG) before and after TIPS. Comparisons used Chi square and Fisher´s exact test for categorical variables and Student´s t test or Mann-Whitney test for quantitative variables.</p><p><strong>Results: </strong>Indication for TIPS was refractory ascites (n = 82) and variceal bleeding (n = 50). The VCX group (n = 85) and the Legacy group (n = 47) had similar new onset overt HE: 37% (31/85) vs 43% (20/47), respectively (p = 0.31); mortality rates (34% [29/85]) vs 39% [18/47], respectively, p = 0.57) and re-bleeding (17% [6/35] vs 20% [3/15], respectively, p = 1.00). Median PPG reduction after TIPS was 10 mmHg (7 - 13) in the VCX group and 12 mmHg (9 - 15) in the Legacy group (p = 0.02). Subgroup analysis revealed post TIPS overt HE rate of 38% (19/50) in the VCX group vs 53% (17/32) in the Legacy group (p = 0.13), with refractory ascites as an indication. Shunt dysfunction rate was 7% (6/85) in the VCX group (stent thrombosis n = 6, stenosis or malpositioning n = 0) and 0% (0/47) in the Legacy group (p = 0.09).</p><p><strong>Conclusion: </strong>VCX stent grafts induce an immediate lower PPG reduction, which might lead to more stent dysfunctions, but also to a reduction in post-TIPS HE.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"48"},"PeriodicalIF":1.2,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12103397/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144136559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Emergency endovascular treatment of stroke due to cervical artery dissection - impact of periprocedural GP IIb/IIIa inhibitor use on clinical outcome.","authors":"Abira Sornalingam, Susanne Wegener, Miranda Stattmann, Jil Baumann, Patrick Thurner, Jawid Madjidyar, Hakim Shakir Husain, Miklos Krepuska, Christoph Globas, Andreas R Luft, Zsolt Kulcsar, Tilman Schubert","doi":"10.1186/s42155-025-00564-9","DOIUrl":"10.1186/s42155-025-00564-9","url":null,"abstract":"<p><strong>Background: </strong>Endovascular therapy (EVT) for large intracranial vessel occlusion or symptomatic hypoperfusion due to cervical artery dissection (CeAD) became the standard therapy in recent years. Stenting is frequently required to secure the dissection with subsequent need for GP IIb/IIIa inhibitors. However, a potential concern of antithrombotic therapy in acute stroke is the increased risk of intracerebral hemorrhage. The aim of the study was to assess the impact of the administration of a GP IIb/IIIa inhibitor imaging during endovascular treatment for acute ischemic stroke caused by CeAD on 90-day clinical outcome and intracranial hemorrhage.</p><p><strong>Methods: </strong>This single-center retrospective cohort study enrolled CeAD patients with internal carotid artery (ICA) dissections treated with EVT from January 2015 to August 2022. We analysed the impact of different variables including postinterventional hemorrhage, revascularization success and the use of GP IIb/IIIa Inhibitors (eptifibatide) on 90-day favorable clinical outcome (mRS 0-2). NIHSS Scores were evaluated at different time points in relation to the 90-day clinical outcomes.</p><p><strong>Results: </strong>Forty-nine patients were included in the study. Thrombectomy was performed in all patients. In 33 patients, stenting was performed in addition to thrombectomy. 20 patients (40.8%) received eptifibatide periinterventionally. 31 out of 49 patients (63.3%) had a favorable 90-day clinical outcome (mRS 0-2). Five patients showed radiologically significant hemorrhage. The rate of successful reperfusion (TICI 2b-3) in the favorable 90-day outcome group was significantly higher than in the unfavorable 90-day outcome group.</p><p><strong>Conclusions: </strong>In this study, the use of a GP IIb/IIIa inhibitor use during EVT for stroke caused by CeAD did not affect 90-day clinical outcome nor the incidence of intracranial hemorrhage. Successful reperfusion significantly correlated with favorable clinical outcome.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"47"},"PeriodicalIF":1.2,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12098224/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144121474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Predicting early clinical success of prostate artery embolization using MRI perfusion in benign prostatic hyperplasia.","authors":"Skander Sammoud, Fabien De Oliviera, Tarek Kammoun, Houssem Loukil, Ghizlane Touimi Ben Jelloun, Sinda Ghabri, Wissem Nabi, Stéphane Droupy, Pascal Gres, Jean-Paul Beregi, Julien Frandon","doi":"10.1186/s42155-025-00562-x","DOIUrl":"10.1186/s42155-025-00562-x","url":null,"abstract":"","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"46"},"PeriodicalIF":1.2,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12095704/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144112350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Accuracy of segment anything model for classification of vascular stenosis in digital subtraction angiography.","authors":"Vagner Navasardyan, Maria Katz, Lukas Goertz, Vazgen Zohranyan, Hayk Navasardyan, Iram Shahzadi, Jan Robert Kröger, Jan Borggrefe","doi":"10.1186/s42155-025-00560-z","DOIUrl":"10.1186/s42155-025-00560-z","url":null,"abstract":"<p><strong>Background: </strong>This retrospective study evaluates the diagnostic performance of an optimized comprehensive multi-stage framework based on the Segment Anything Model (SAM), which we named Dr-SAM, for detecting and grading vascular stenosis in the abdominal aorta and iliac arteries using digital subtraction angiography (DSA).</p><p><strong>Materials and methods: </strong>A total of 100 DSA examinations were conducted on 100 patients. The infrarenal abdominal aorta (AAI), common iliac arteries (CIA), and external iliac arteries (EIA) were independently evaluated by two experienced radiologists using a standardized 5-point grading scale. Dr-SAM analyzed the same DSA images, and its assessments were compared with the average stenosis grading provided by the radiologists. Diagnostic accuracy was evaluated using Cohen's kappa, specificity, sensitivity, and Wilcoxon signed-rank tests.</p><p><strong>Results: </strong>Interobserver agreement between radiologists, which established the reference standard, was strong (Cohen's kappa: CIA right = 0.95, CIA left = 0.94, EIA right = 0.98, EIA left = 0.98, AAI = 0.79). Dr-SAM showed high agreement with radiologist consensus for CIA (κ = 0.93 right, 0.91 left), moderate agreement for EIA (κ = 0.79 right, 0.76 left), and fair agreement for AAI (κ = 0.70). Dr-SAM demonstrated excellent specificity (up to 1.0) and robust sensitivity (0.67-0.83). Wilcoxon tests revealed no significant differences between Dr-SAM and radiologist grading (p > 0.05).</p><p><strong>Conclusion: </strong>Dr-SAM proved to be an accurate and efficient tool for vascular assessment, with the potential to streamline diagnostic workflows and reduce variability in stenosis grading. Its ability to deliver rapid and consistent evaluations may contribute to earlier detection of disease and the optimization of treatment strategies. Further studies are needed to confirm these findings in prospective settings and to enhance its capabilities, particularly in the detection of occlusions.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"45"},"PeriodicalIF":1.2,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12089558/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144095797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pipeline flow diverter and transvenous coiling for the treatment of direct carotid cavernous sinus fistulae: a retrospective case series.","authors":"Omar Abu-Fares, Antonis Adamou, Heinrich Lanfermann, Joachim K Krauss, Shadi Al-Afif, Katja Döring","doi":"10.1186/s42155-025-00566-7","DOIUrl":"10.1186/s42155-025-00566-7","url":null,"abstract":"<p><strong>Background: </strong>Carotid cavernous fistulae (CCF) are pathological connections between the carotid arteries and the cavernous sinus. Endovascular procedures are the mainstay treatment for CCF. The aim of this report is to evaluate the efficacy and safety of the combined use of the Pipeline Vantage (PV) flow diverter and transvenous coil embolization in the treatment of CCF.</p><p><strong>Methods: </strong>Retrospective,monocentric analysis of three patients who underwent neurointerventional treatment of clinically symptomatic CCF using a combination of transvenous coil embolization and flow diverter Implantation. Clinical data, the etiology of the CCF and clinical and radiological follow up were evaluated.</p><p><strong>Results: </strong>Clinical and radiological follow-up were available at 3 and 12 months. One patient experienced clinical improvement immediatley after the interventions. The other two patients improved within one year after treatment. No symptomatic complications were recorded. One year after the intervention complete CCF occulsion was documented in all cases.</p><p><strong>Conclusions: </strong>We report an initial experience for the treatment of direct CCF using the combination of a new generation Pipeline FD and transvenous coil embolization. The high treatment success rate and low complication rate are encouraging.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"44"},"PeriodicalIF":1.2,"publicationDate":"2025-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12085412/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144086919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Iliofemoral DVT thrombectomy: a dual-access approach to optimise inflow.","authors":"Robert Wise, Zahi Qamhawi, Emma Wilton, Andrew Wigham","doi":"10.1186/s42155-025-00543-0","DOIUrl":"10.1186/s42155-025-00543-0","url":null,"abstract":"","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"43"},"PeriodicalIF":1.2,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12081790/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Learning curve in the endovascular treatment of chronic post-thrombotic syndrome in a French center.","authors":"Paul Segui, Valérie Monnin-Barès, Monira Nou, Sébastien Bommart, Hamid Zarqane, Juliette Vanoverschelde, Hélène Vernhet-Kovacsik","doi":"10.1186/s42155-025-00561-y","DOIUrl":"10.1186/s42155-025-00561-y","url":null,"abstract":"<p><strong>Purpose: </strong>Chronic post-thrombotic syndrome (PTS) is a frequent and disabling complication of deep vein thrombosis (DVT) with significant clinical impact. Endovascular stenting (EVS) has established itself as an effective technique but its availability remains limited to expert centers. We sought to identify the key determinants of our learning curve in EVS for PTS and the impact of this experience on our short and long-term results, in order to facilitate territorial dissemination and respond effectively to clinical demand.</p><p><strong>Material and methods: </strong>We reviewed the records of 68 patients treated in our centre during eight years. We collected patients and disease characteristics, technical elements of the procedure, peri-procedural medical management and detail of the clinical follow-up and imaging.</p><p><strong>Results: </strong>The median follow-up was 37 months. The primary, primary assisted and secondary patency rates were respectively 74%, 86% and 95%. A clinical benefit was observed in all patients from the start of our activity, without significant change whatever the operator experience. The main determinants of our learning curve were a progressive mastery of the procedure in its technicality and preparation, the evolution of the material and the improvement of the peri procedural management, allowing to reduce the duration of intervention, the rate of endovascular revision (38% to 4%, p < 0.01) but also the number of remote thrombotic events (29% to 6%).</p><p><strong>Conclusion: </strong>EVS appears to be an effective therapeutic option in the management of PTS, with consistent clinical improvement observed even when performed by less experienced operators. Improvement in this technique comes with faster procedures, and a reduction of the occurrence of peri-procedural and long term thrombotic events. The implementation of this type of procedure requires multi-disciplinary collaboration with vascular medicine and corresponding angiologists.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"42"},"PeriodicalIF":1.2,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12078848/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144064678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Endovascular management of acute superior mesenteric vein thrombosis: a retrospective study on thrombolysis outcomes.","authors":"Nan Wei, René Michael Mathy, De-Hua Chang, Martin Loos, Uta Merle, Annika Gauss, Monica Boxberger, Philipp Mayer, Miriam Klauss, Hans-Ulrich Kauczor, Osman Öcal, Mark O Wielpütz","doi":"10.1186/s42155-025-00558-7","DOIUrl":"10.1186/s42155-025-00558-7","url":null,"abstract":"<p><strong>Background: </strong>Acute superior mesenteric vein thrombosis (ASMVT) is a rare but life-threatening condition associated with high morbidity and mortality. While anticoagulation remains the standard treatment, endovascular therapies such as thrombolysis, thrombectomy, and angioplasty are increasingly utilized in selected cases. However, evidence on their outcomes remains limited. This study retrospectively reports the clinical outcomes of ASMVT patients treated with endovascular combination therapies.</p><p><strong>Methods: </strong>Between August 2019 and May 2024, 12 patients (males = 9; mean age, 52.33 ± 12.51 years) were diagnosed with ASMVT. The study collected comprehensive data on demographic details, presenting symptoms, etiology, treatment modalities, response to treatment, and follow-up outcomes. Computed Tomography (CT) was available from diagnosis, and an average of 6.3 CT scans with a median follow-up of 3 months (IQR: 2-20 months).</p><p><strong>Results: </strong>The average time from symptom onset to angiographic treatment initiation was 8.0 ± 4.71 days, preceded by anticoagulation with heparin from the time of diagnosis. Patients were treated with combination therapy involving endovascular thrombolysis, rheolytic thrombectomy, and balloon angioplasty via transjugular (n = 9, 75%) or percutaneous (n = 3, 25%) approaches. Thrombolysis was performed with an average recombinant tissue plasminogen activator (rt-PA) infusion duration of 2.75 ± 1.14 days and a total dose of 61.25 ± 18.48 mg rt-PA. Superior mesenteric vein (SMV) flow was initially restored almost completely in 58.3% and partially in 41.7% of patients. Complications observed were hepatic artery bleeding (n = 2, 16.7%), hepatic arteriovenous fistula (n = 1, 8.3%), hepatic parenchymal bleeding (n = 1, 8.3%), melena (n = 1, 8.3%), and nostril bleeding (n = 1, 8.3%). Two patients experienced worsening symptoms of post-intervention, leading to bowel resection revealing intestinal necrosis. SMV patency was almost complete in 25%, and partially in 25% of patients at follow-up.</p><p><strong>Conclusion: </strong>Endovascular combination therapy with long-term thrombolysis and thrombectomy in patients with ASMVT demonstrated promising technical outcomes. In view of complications, individual indication for intervention needs to be confirmed in a multidisciplinary team.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"41"},"PeriodicalIF":1.2,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12078909/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144042876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Bronchial artery embolization for the treatment of hemoptysis: permanent versus temporary embolic materials, a single center study.","authors":"Taninokuchi Tomassoni Makoto, Perini Daniele, Porta Francesco, Braccischi Lorenzo, Zanella Sara, Basile Antonio, Modestino Francesco, Mosconi Cristina","doi":"10.1186/s42155-025-00554-x","DOIUrl":"https://doi.org/10.1186/s42155-025-00554-x","url":null,"abstract":"<p><strong>Background: </strong>Bronchial artery embolization (BAE) is a common interventional radiology technique used to control significant bleeding from the bronchial circulation, especially in cases of severe hemoptysis or pulmonary hemorrhage. The choice of embolizing agents plays a key role in the success, recurrence of bleeding, and safety of the procedure. However, there is no consensus on the ideal embolizing agent. This study compares the efficacy, safety, and long-term outcomes of using permanent versus temporary embolizing agents in BAE.</p><p><strong>Methods: </strong>This retrospective cohort study included patients who underwent BAE at our institution from July 2006 to May 2024. Inclusion criteria encompassed patients with hemoptysis requiring intervention, complete clinical and radiological data, and BAE with either permanent (e.g., coils, PVA particles) or temporary (e.g., gelatin sponge) embolic materials. Exclusion criteria included non-bronchial causes of hemoptysis, BAE as part of a lung transplant protocol, or use of combined embolic materials. Primary outcomes included early clinical success (cessation of bleeding during the procedure and no recurrence within a week) and late clinical success (no bleeding recurrence within 6 months). Secondary outcomes focused on procedural complications, such as pneumonia, lung infarction, or bronchial ischemia.</p><p><strong>Results: </strong>This retrospective study included a total of ninety-four procedures performed in eighty-five patients (56 males, 29 females; mean age 59; age range 8-92 years) who were admitted for BAE between July 2006 and May 2024. Permanent embolic materials were used in 59 procedures (64%), in most cases were used particles and glue (39% and 21%, respectively), while temporary embolizing materials (gelatin sponge) were used in 35 procedures (37%). Statistical analysis showed a superiority in terms of clinical outcomes in favor of permanent embolic materials (p-value 0,047).</p><p><strong>Conclusions: </strong>BAE is a safe procedure for control of hemoptysis of varying etiologies and possesses high rates of immediate clinical success with few complications. In terms of embolic materials, a superiority in term of late clinical success and lower hemorrhage recurrency rate with permanent materials were clearly observed in our population, with a similar safety profile. Further studies are needed to confirm our findings and strengthen evidence.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"40"},"PeriodicalIF":1.2,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12058560/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144049556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}